Final trial report of sentinel-node biopsy versus nodal observation in melanoma
View abstract on PubMed
Summary
This summary is machine-generated.Sentinel-node biopsy improves disease-free survival in melanoma patients. This minimally invasive staging identifies those with nodal metastases who benefit from immediate lymphadenectomy, enhancing survival outcomes.
Area Of Science
- Oncology
- Surgical Oncology
- Dermatology
Background
- Sentinel-node biopsy is a minimally invasive procedure for regional melanoma staging.
- A phase 3 trial evaluated the efficacy of sentinel-node biopsy versus nodal observation.
Purpose Of The Study
- To compare outcomes between sentinel-node biopsy and nodal observation in primary cutaneous melanoma patients.
- To determine if sentinel-node biopsy improves survival rates and prognostic information.
Main Methods
- 2001 patients with primary cutaneous melanomas were randomized to wide excision with nodal observation or wide excision with sentinel-node biopsy.
- Outcomes including melanoma-specific survival and disease-free survival were evaluated over 10 years.
- Accelerated-failure-time latent-subgroup analysis was used to account for initial nodal status differences.
Main Results
- Sentinel-node biopsy significantly improved 10-year disease-free survival in patients with intermediate-thickness (1.20-3.50 mm) and thick (>3.50 mm) melanomas.
- For patients with intermediate-thickness melanomas and nodal metastases, biopsy-based management improved distant disease-free survival and melanoma-specific survival.
- No significant difference in 10-year melanoma-specific survival was observed in the overall study population.
Conclusions
- Sentinel-node biopsy provides crucial prognostic information for intermediate-thickness or thick melanomas.
- It identifies patients with nodal metastases who benefit from immediate lymphadenectomy, prolonging disease-free survival.
- Biopsy-based management enhances distant disease-free and melanoma-specific survival in specific patient subgroups.